Accessibility Menu
 

Tectonic Therapeutic

(NASDAQ) TECX

Current Price$27.59
Market Cap$544.52M
Since IPO (2024)+70%
5 Year-74%
1 Year+39%
1 Month-10%

Tectonic Therapeutic Financials at a Glance

Market Cap

$544.52M

Revenue (TTM)

$0.00

Net Income (TTM)

$83.49M

EPS (TTM)

$-4.46

P/E Ratio

-6.51

Dividend

$0.00

Beta (Volatility)

1.26 (Average)

Price

$27.59

Volume

548,549

Open

$28.99

Previous Close

$27.52

Daily Range

$26.98 - $30.27

52-Week Range

$14.38 - $36.03

TECX News

TECX: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tectonic Therapeutic

Industry

Biotechnology

Employees

60

CEO

Alise S. Reicin, MD

Headquarters

Watertown, MA 02472, US

TECX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-31%

Return on Capital

-40%

Return on Assets

-34%

Earnings Yield

-15.36%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$544.52M

Shares Outstanding

18.78M

Volume

548.55K

Avg. Volume

345.16K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$84.04M

EBITDA

$71.48M

Operating Cash Flow

$60.08M

Capital Expenditure

$208.00K

Free Cash Flow

$60.29M

Cash & ST Invst.

$253.80M

Total Debt

$1.28M

Tectonic Therapeutic Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$544.52M

N/A

Market Cap/Employee

$10.68M

N/A

Employees

51

N/A

Net Income

$25.24M

-58.7%

EBITDA

$27.30M

-75.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$232.26M

-23.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$3.20M

+1031.4%

Short Term Debt

$1.43M

-39.1%

Return on Assets

-33.86%

N/A

Return on Invested Capital

-39.83%

N/A

Free Cash Flow

$0.00

+100.0%

Operating Cash Flow

$0.00

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DBVTDBV Technologies S.A.
$20.36+3.19%
LYELLyell Immunopharma, Inc.
$19.20-0.67%
CLLSCellectis S.A.
$3.98+3.38%
LRMRLarimar Therapeutics, Inc.
$4.09+3.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$16.84+0.08%
NOKNokia
$13.92+0.09%
POETPoet Technologies
$13.90+0.27%
ACHRArcher Aviation
$6.54+0.01%

Questions About TECX

What is the current price of Tectonic Therapeutic?

Tectonic Therapeutic is trading at $27.52 per share.

What is the 52-week range for Tectonic Therapeutic?

Over the past 52 weeks, Tectonic Therapeutic has traded between $14.39 and $36.03.

How much debt does Tectonic Therapeutic have?

As of the most recent reporting period, Tectonic Therapeutic reported total debt of $1.28M.

How much cash does Tectonic Therapeutic have on hand?

Tectonic Therapeutic reported $236.89M in cash and cash equivalents in its most recent financial results.

What is Tectonic Therapeutic’s dividend yield?

Tectonic Therapeutic does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.